Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

TGA Approval

RIFADIN rifampicin 20mg/mL oral liquid bottle (10113)

ARTG ID

10113

ARTG Name

RIFADIN rifampicin 20mg/mL oral liquid bottle

Sponsor

Sanofi-Aventis Australia Pty Ltd

ARTG Date

July 8, 1991

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sanofi-Aventis Australia Pty Ltd

Sponsor Item Name

SANOFI-AVENTIS AUSTRALIA PTY LTD

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/154dc6dcd61a7976ad3d9183f03d5d74.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/98ca4d3ab15bef304839254546b5aa37.pdf

Active Ingredients

Ingredient Name

rifampicin

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

RIFADIN rifampicin 20mg/mL oral liquid bottle (10113) - TGA 批准文号 | MedPath